Deborah Crouch

Array ( [id] => 6614867 [patent_doc_number] => 20100310523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene' [patent_app_type] => utility [patent_app_number] => 12/584657 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13401 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310523.pdf [firstpage_image] =>[orig_patent_app_number] => 12584657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487362 [patent_doc_number] => 20110236362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM' [patent_app_type] => utility [patent_app_number] => 13/062453 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 13992 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236362.pdf [firstpage_image] =>[orig_patent_app_number] => 13062453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102121 [patent_doc_number] => 20110165613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'STABLE CLONE CELL EXPRESSING A PRION' [patent_app_type] => utility [patent_app_number] => 13/062475 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12042 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165613.pdf [firstpage_image] =>[orig_patent_app_number] => 13062475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323483 [patent_doc_number] => 20100196963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/547422 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20449 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196963.pdf [firstpage_image] =>[orig_patent_app_number] => 12547422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464980 [patent_doc_number] => 20090325180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/543875 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13736 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325180.pdf [firstpage_image] =>[orig_patent_app_number] => 12543875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956242 [patent_doc_number] => 08502017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Rodent model of central neuropathic pain' [patent_app_type] => utility [patent_app_number] => 12/541754 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 6978 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12541754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10888157 [patent_doc_number] => 08912153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'HDAC4 nucleic acid administration to treat retinal disease' [patent_app_type] => utility [patent_app_number] => 13/058346 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6290206 [patent_doc_number] => 20100158975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/509171 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 20902 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158975.pdf [firstpage_image] =>[orig_patent_app_number] => 12509171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527554 [patent_doc_number] => 20100015091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/504612 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 11686 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015091.pdf [firstpage_image] =>[orig_patent_app_number] => 12504612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533635 [patent_doc_number] => 08309791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Method for producing a transgenic pig using a hyper-methylated transposon' [patent_app_type] => utility [patent_app_number] => 12/504364 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19228 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413417 [patent_doc_number] => 20100166824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/501312 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20191 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166824.pdf [firstpage_image] =>[orig_patent_app_number] => 12501312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5468167 [patent_doc_number] => 20090328241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'MITOCHONDRIAL-NUCLEAR EXCHANGED CELLS, TISSUES, ORGANS AND ANIMALS' [patent_app_type] => utility [patent_app_number] => 12/486375 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8173 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0328/20090328241.pdf [firstpage_image] =>[orig_patent_app_number] => 12486375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756519 [patent_doc_number] => 20120028821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'PROGRAMMING AND REPROGRAMMING OF CELLS' [patent_app_type] => utility [patent_app_number] => 12/997815 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 34812 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028821.pdf [firstpage_image] =>[orig_patent_app_number] => 12997815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4444334 [patent_doc_number] => 07863002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Breeding and milking cows for milk free of β-casein A1 ' [patent_app_type] => utility [patent_app_number] => 12/484863 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 15543 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863002.pdf [firstpage_image] =>[orig_patent_app_number] => 12484863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6382749 [patent_doc_number] => 20100316997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Cell Markers for Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/483434 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4538 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316997.pdf [firstpage_image] =>[orig_patent_app_number] => 12483434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375151 [patent_doc_number] => 08257941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Methods and platforms for drug discovery using induced pluripotent stem cells' [patent_app_type] => utility [patent_app_number] => 12/484163 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30774 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12484163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10184318 [patent_doc_number] => 09213999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'Providing iPSCs to a customer' [patent_app_type] => utility [patent_app_number] => 12/484152 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23321 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12484152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397271 [patent_doc_number] => 20090317334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'OPTICAL DETECTION METHOD OR IMAGING METHOD OF IMPLANTED CELLS' [patent_app_type] => utility [patent_app_number] => 12/481948 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7545 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317334.pdf [firstpage_image] =>[orig_patent_app_number] => 12481948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367845 [patent_doc_number] => 20090305404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods and compositions relating to blastomere-derived human embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 12/455954 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9761 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305404.pdf [firstpage_image] =>[orig_patent_app_number] => 12455954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540222 [patent_doc_number] => 08058065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Oct3/4, Klf4, c-Myc and Sox2 produce induced pluripotent stem cells' [patent_app_type] => utility [patent_app_number] => 12/457356 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 29475 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058065.pdf [firstpage_image] =>[orig_patent_app_number] => 12457356 [rel_patent_id] =>[rel_patent_doc_number] =>)